|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
In addition, BC-PIV with antigenic epitopes of both melanoma gp100 and WT1 tumor antigen induced a CD8+ T-cell-mediated response in tumor-transplanted syngeneic mice.
|
31501502 |
2019 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
The Wilms' tumor oncogene protein (WT1) is a highly validated tumor antigen for immunotherapy.
|
28344864 |
2017 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
Mice were immunized with peptides corresponding to the CD8(+) T-cell epitopes of a malaria antigen, a circumsporozoite protein of Plasmodium yoelii, and a tumor antigen, a Wilms Tumor antigen-1 (WT-1), together with 7DW8-5 and MPLA, as an adjuvant.
|
27132023 |
2016 |
|
LINC01194
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of Wilms' tumor gene 1 (WT1), the highest ranked tumor antigen, is attractive for immunotherapy.
|
24324087 |
2013 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
|
22510877 |
2012 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
The strategy was successfully used to establish LCLs expressing Wilms' tumor gene 1 (WT1) tumor antigen (WT1-LCLs), which is an attractive target for cancer immunotherapy.
|
22722376 |
2012 |
|
LINC01194
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Wilms' tumor gene (WT1), which is expressed in human pancreatic cancer (PC), is a unique tumor antigen recognized by T-cell-mediated antitumor immune response.
|
21607557 |
2011 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
The Wilms' tumor antigen (WT1) is an attractive target for immunotherapy of leukemia.
|
19679884 |
2010 |
|
LINC01194
|
0.090 |
Biomarker
|
disease |
BEFREE |
The aim of this study is to extend these observations to a self-protein and clinically relevant tumor antigen associated with most types of adult leukemia: Wilms tumor gene 1 (WT1).
|
19752749 |
2009 |